Edition:
India

GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,498.60GBp
18 Jan 2019
Change (% chg)

16.80 (+1.13%)
Prev Close
1,481.80
Open
1,490.40
Day's High
1,504.20
Day's Low
1,480.20
Volume
6,405,711
Avg. Vol
8,590,961
52-wk High
1,648.80
52-wk Low
1,235.20

Latest Key Developments (Source: Significant Developments)

Exagen Extended Agreement With GSK
Wednesday, 2 Jan 2019 

Jan 2 (Reuters) - EXAGEN::EXAGEN - EXTENDED ITS AGREEMENT WITH GSK.EXAGEN - DETAILS OF AGREEMENT ARE CONFIDENTIAL.  Full Article

Epizyme Earns $8 Mln Milestone Payment From Glaxosmithkline For Initiation Of Clinical Development For First-In-Class Prmt1 Inhibitor
Tuesday, 18 Dec 2018 

Dec 18 (Reuters) - Epizyme Inc ::EPIZYME EARNS $8 MILLION MILESTONE PAYMENT FROM GLAXOSMITHKLINE FOR INITIATION OF CLINICAL DEVELOPMENT FOR FIRST-IN-CLASS PRMT1 INHIBITOR.EPIZYME INC - CO GRANTED GSK EXCLUSIVE WORLDWIDE LICENSE RIGHTS TO METHYLTRANSFERASE INHIBITORS DIRECTED TO 3 TARGETS.EPIZYME INC - EARNED AGGREGATE OF $89 MILLION IN UP-FRONT, RESEARCH & MILESTONE PAYMENTS TO DATE.EPIZYME INC - MAY RECEIVE UPTO ADDITIONAL $375 MILLION FROM GSK IF ALL REMAINING MILESTONES ARE MET.EPIZYME INC - ELIGIBLE TO RECEIVE UP TO DOUBLE-DIGIT ROYALTIES ON WORLDWIDE NET SALES OF COLLABORATION PRODUCTS.  Full Article

GSK Commences Tender Offer For Tesaro Inc
Friday, 14 Dec 2018 

Dec 14 (Reuters) - GlaxoSmithKline PLC ::GLAXOSMITHKLINE PLC - GSK COMMENCES TENDER OFFER FOR TESARO INC.GLAXOSMITHKLINE PLC - COMMENCING CASH TENDER OFFER FOR ALL OF ISSUED, OUTSTANDING SHARES OF COMMON STOCK OF TESARO FOR PRICE OF $75.00 PER SHARE.GLAXOSMITHKLINE - TENDER OFFER COMMENCED ON DECEMBER 14, 2018 AND WILL EXPIRE ON JANUARY 14, 2019.  Full Article

Vectura Says Considering Options Regarding GSK Patent Litigation
Thursday, 13 Dec 2018 

Dec 13 (Reuters) - Vectura Group PLC ::UPDATE ON UK GSK PATENT LITIGATION.WILL BE CONSIDERING OUR OPTIONS REGARDING COURT DECISION, WHICH COULD INCLUDE SEEKING PERMISSION TO APPEAL.JUDGEMENT IN ACTION BY GSK AGAINST CO IN RELATION TO SOME MORE PATENTS UNDER PATENT LICENCE AND OPTION AGREEMENT WITH VECTURA.COURT'S "OVERALL RULING IN FAVOUR OF GSK" FOR THE LITIGATION.  Full Article

Neurometrix Reports Agreement With GSK Healthcare On 2019 Quell Development Program
Wednesday, 12 Dec 2018 

Dec 11 (Reuters) - NeuroMetrix Inc ::NEUROMETRIX REPORTS AGREEMENT WITH GSK HEALTHCARE ON 2019 QUELL JOINT DEVELOPMENT PROGRAM AND MODIFICATION TO STRATEGIC COLLABORATION.PARTIES MODIFIED TERMS OF COLLABORATION TO REALLOCATE UP TO $13.8 MILLION REMAINING TO BE PAID BY GSK.REPORTED AGREEMENT REACHED ON 2019 DEVELOPMENT PROGRAM AND IT WILL COMMENCE IN JANUARY 2019.MODIFICATIONS ACCELERATED PORTION OF REMAINING MILESTONES TIMING INTO NEXT 12 MONTHS.NEUROMETRIX RECEIVED A $2 MILLION MILESTONE PAYMENT FROM GSK IN CONNECTION WITH MODIFICATIONS.MODIFICATIONS REDUCED AGGREGATE MILESTONE AMOUNT PAYABLE BY AN INTEREST CHARGE.  Full Article

Crown Laboratories Acquires Select Consumer Healthcare Brands From Glaxosmithkline
Friday, 30 Nov 2018 

Nov 30 (Reuters) - Crown Laboratories ::CROWN LABORATORIES ACQUIRES SELECT CONSUMER HEALTHCARE BRANDS FROM GLAXOSMITHKLINE.FINANCIAL TERMS OF TRANSACTION WERE NOT DISCLOSED.HAS ACQUIRED NORTH AMERICAN DISTRIBUTION RIGHTS OF 5 OTC CONSUMER BRANDS FROM GLAXOSMITHKLINE.SAYS HAYFIN CAPITAL MANAGEMENT, LLP PROVIDED DEBT FINANCING IN CONNECTION WITH TRANSACTION.  Full Article

GSK Says Considering Potential Deal Including Merger Of Its Consumer Healthcare Unit
Thursday, 29 Nov 2018 

Nov 29 (Reuters) - GlaxoSmithKline Plc ::UPDATE ON REVIEW OF HORLICKS.GSK CONFIRMS THAT CONSIDERATION IS BEING GIVEN TO A POTENTIAL TRANSACTION THAT INCLUDES A MERGER OF GSKCH.MAJORITY OF HORLICKS AND OTHER GSK NUTRITION PRODUCTS SALES ARE GENERATED IN INDIA BY GLAXOSMITHKLINE CONSUMER HEALTHCARE LIMITED.  Full Article

Novitium Pharma Launches Ranitidine Capsules
Wednesday, 28 Nov 2018 

Nov 28 (Reuters) - Novitium Pharma LLC::NOVITIUM PHARMA LAUNCHES RANITIDINE CAPSULES.NOVITIUM PHARMA LLC - RECEIVED FDA APPROVAL ON ITS ABBREVIATED NEW DRUG APPLICATION FOR RANITIDINE CAPSULES 150 MG AND 300 MG .NOVITIUM PHARMA LLC - RANITIDINE IS A THERAPEUTIC EQUIVALENT TO REFERENCE LISTED DRUG ZANTAC OF GLAXOSMITHKLINE PLC .  Full Article

GSK, Kyowa Hakko Kirin Sign Commercialisation Deal In Japan For Daprodustat
Thursday, 22 Nov 2018 

Nov 22 (Reuters) - GlaxoSmithKline Plc ::GSK AND KYOWA HAKKO KIRIN SIGN STRATEGIC COMMERCIALISATION DEAL IN JAPAN FOR DAPRODUSTAT.  Full Article

GSK Submits U.S. Regulatory Filing To Expand Nucala Use
Monday, 19 Nov 2018 

Nov 19 (Reuters) - GlaxoSmithKline PLC ::GLAXOSMITHKLINE PLC - GSK SUBMITS US REGULATORY FILING TO EXPAND USE OF NUCALA IN CHILDREN WITH SEVERE EOSINOPHILIC ASTHMA.  Full Article

UK Stocks-Factors to watch on Jan 9

Jan 9 - Britain's FTSE 100 index is seen opening 75 points higher at 6,936 on Wednesday, according to financial bookmakers. * INTERNATIONAL CONSOLIDATED AIRLINES: Brussels has warned British Airways owner IAG that its favoured strategy to allow it to continue flying freely in and around Europe in the event of a no-deal Brexit will not work, the Financial Times reported on Tuesday. * FAROE PETROLEUM: Norwegian oil company DNO ASA said on Tuesday it raised its cash offer for Faroe Petr